Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 24,774 shares of the company's stock, valued at approximately $2,450,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.13% of Addus HomeCare as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also added to or reduced their stakes in the business. Natixis boosted its position in Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after purchasing an additional 132 shares during the last quarter. Meeder Asset Management Inc. purchased a new position in shares of Addus HomeCare in the 4th quarter worth about $77,000. Bailard Inc. purchased a new stake in Addus HomeCare during the 1st quarter valued at about $208,000. Heritage Family Offices LLP lifted its holdings in Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after buying an additional 143 shares during the period. Finally, Private Advisor Group LLC lifted its stake in shares of Addus HomeCare by 52.4% in the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock valued at $252,000 after purchasing an additional 875 shares during the period. 95.35% of the stock is currently owned by institutional investors.
Insider Transactions at Addus HomeCare
In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total transaction of $235,175.00. Following the transaction, the executive vice president owned 7,796 shares of the company's stock, valued at $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 4.60% of the company's stock.
Addus HomeCare Stock Down 1.7%
Shares of ADUS stock traded down $1.82 on Friday, reaching $104.96. 199,141 shares of the stock were exchanged, compared to its average volume of 189,302. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.20. The business's 50 day moving average price is $112.05 and its 200 day moving average price is $108.95. The company has a market capitalization of $1.93 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 1.53 and a beta of 0.81. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. The business had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The business's revenue was up 20.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.21 earnings per share. As a group, sell-side analysts expect that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several analysts recently commented on the company. JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a report on Wednesday, July 16th. Macquarie reaffirmed an "outperform" rating and issued a $133.00 target price on shares of Addus HomeCare in a report on Tuesday, June 10th. Finally, Wall Street Zen raised Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. Seven equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $142.57.
Check Out Our Latest Report on ADUS
Addus HomeCare Company Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.